Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Redburn Partners Upgrades Morningstar to Buy

Redburn Partners Upgrades Morningstar to Buy

Redburn Partners analyst Russell Quelch upgrades Morningstar (NASDAQ:MORN) from Neutral to Buy.

byBenzinga Newsdesk

September 20, 2022

1 minute read

Redburn Partners analyst Russell Quelch upgrades Morningstar (NASDAQ:MORN) from Neutral to Buy.

Seelos Therapeutics Positive Q1 Financials Make For ‘The Most Important Year’ In Company’s History

By Lara Goldstein

May 16, 5:30 PM

Clinical-stage biopharma company Seelos Therapeutics Inc. (NASDAQ: SEEL) reported financial results and clinical updates corresponding to the first quarter ended March 31, 2023. Quarterly numbers show:

SEEL

Analyst Ratings

Analyst Ratings for TPG

By Benzinga Insights

July 8, 10:09 AM

Within the last quarter, TPG (NASDAQ:TPG) has observed the following analyst ratings:

TPG

Citigroup Maintains Buy on NIO, Lowers Price Target to $31.3

By Benzinga Newsdesk

September 8, 7:44 AM

Citigroup analyst Jeff Chung maintains NIO (NYSE:NIO) with a Buy and lowers the price target from $41.1 to $31.3.

NIO

Analyst Ratings

What 4 Analyst Ratings Have To Say About IDEX

By Benzinga Insights

October 19, 4:00 PM

IDEX (NYSE:IEX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

IEX

Redburn Partners Upgrades Morningstar to Buy

Related Posts

Seelos Therapeutics Positive Q1 Financials Make For ‘The Most Important Year’ In Company’s History

Analyst Ratings for TPG

Citigroup Maintains Buy on NIO, Lowers Price Target to $31.3

What 4 Analyst Ratings Have To Say About IDEX